Conceivably, a consequence of this N-Myc dependent GLS2 activation is the reprogramming of mitochondrial metabolism to depend on glutamine catabolism to sustain cellular viability and TCA cycle anapleurosis, triggering neuroblastoma cellular addiction to glutamine as a bioenergetic substrate. The gene discussed is MYCN; the disease is neuroblastoma.